Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma
Open Access
- 29 January 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 82 (6) , 1414-1431
Abstract
Background and Aims: Immune checkpoint inhibitors have revolutionized systemic HCC treatment. Nevertheless, numerous patients are refractory to immune checkpoint inhibitor therapy. It is currently unknown whether diet therapies such as short-term starvation (STS) combined with immune checkpoint inhibitors can be used to treat HCC. This study aimed to investigate whether STS could sensitize HCC tumors to immunotherapy. Approach and Results: STS was found to attenuate tumor progression by inducing tumor-associated macrophages (TAMs) to switch to an antitumoral phenotype, enhancing phagocytosis of tumor cells, and stimulating subsequent antitumor immunity of CD8 + T cells as demonstrated in 3 HCC mouse models, NCG mice, and Rag2-KO mice. Furthermore, STS combined with anti-programmed cell death 1/ligand 1 (anti-PD-1/L1) suppressed tumor progression, while the efficacy of PD-L1 was improved when combined with STS. Mechanistically, TAM-derived exosomal PD-L1 (exoPD-L1) impairs the efficacy of anti-PD-1/L1. STS attenuates exoPD-L1 secretion from TAM by regulating the fructose diphosphatase 1 (FBP1) /Akt/Rab27a axis. Modulating FBP1/Akt/Rab27a axis potentiates the anti-PD-L1 response using 2 liposomal delivery systems and macrophage adoptive transfer. Conclusions: This study describes the immunomodulatory effects of STS and provides a rationale for its application as an adjuvant in HCC immunotherapy.Keywords
This publication has 43 references indexed in Scilit:
- Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityCell Reports, 2023
- Monocytes re-enter the bone marrow during fasting and alter the host response to infectionImmunity, 2023
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effectsCell Reports, 2022
- Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escapeCell Metabolism, 2021
- The Bone Marrow Protects and Optimizes Immunological Memory during Dietary RestrictionCell, 2019
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and MemoryCell, 2019
- Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cellsJournal of Cellular Physiology, 2017
- Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceCancer Cell, 2016
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor CytotoxicityCancer Cell, 2016